Mode
Text Size
Log in / Sign up

California's COVID-19 stay-at-home order associated with affected cervical cancer screening rates

California's COVID-19 stay-at-home order associated with affected cervical cancer screening rates
Photo by Cht Gsml / Unsplash
Key Takeaway
Note: Observational report links stay-at-home order to affected cervical screening rates; magnitude unknown.

An observational report examined the impact of California's COVID-19 pandemic stay-at-home order on cervical cancer screening rates. The study population consisted of women aged 21 to 65 years within a large integrated health care system in Southern California. The primary outcome was cervical cancer screening rates, with the exposure being the implementation of the state's stay-at-home order. No comparator group or specific follow-up period was reported.

The main finding was that cervical cancer screening rates were affected. However, the report did not provide the effect size, direction of the effect (increase or decrease), absolute numbers, or statistical measures such as p-values or confidence intervals. This limits the ability to understand the magnitude or statistical significance of the observed association.

No safety or tolerability data related to screening were reported. Key limitations include the observational nature of the report, which precludes establishing causality, and the lack of quantitative data on the screening rate changes. The practice relevance is restrained; the report signals a potential association between public health mandates and preventive service utilization that clinicians should be aware of, but it does not provide actionable data on the scale of the disruption.

Study Details

EvidenceLevel 5
PublishedJan 2021
View Original Abstract ↓
This report describes how California's stay-at-home order during the COVID-19 pandemic has affected cervical cancer screening rates.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.